Introduced
by
To define the form the Department of Community Heath would use under the mandate proposed by House Bill 6568 for reporting of human clinical trials conducted or sponsored in this state by pharmaceutical makers. The form would require disclosure of the results of the trial, including any adverse effects of the drug.
Referred to the Committee on Health Policy
